期刊文献+

人工流产术后即时服用屈螺酮炔雌醇的临床应用 被引量:3

Clinical observation on immediate use of drospirenone-ethinylestradiol tablets after artificial abortion
暂未订购
导出
摘要 目的探讨人工流产术后即时服用屈螺酮炔雌醇的临床效果。方法将自愿要求行人工流产术终止妊娠的健康育龄妇女300例分为两组,人工流产术后即时服用屈螺酮炔雌醇者为观察组(150例),术后采取其他方式避孕者为对照组(150例)。观察两组术后出血量、出血时间、月经恢复情况及宫腔粘连情况。结果观察组术后出血量少、出血时间短、月经恢复快,与对照组比较差异有统计学意义(P均<0.01),无宫腔粘连情况。结论人工流产术后即时服用屈螺酮炔雌醇片避孕效果好,同时有调经预防宫腔粘连的作用。 Objective To explore the effect of immediate use of drospirenone-ethinylestradiol tablets after abortion in women undergoing artificilal abortion. Methods A total of 300 women who undergoing artificial abortion were divided into two groups. In observation group, 150 women took drospirenone-ethinylestradiol tablets immediately after abortion and in control group 150 women took other methods. The volume and duration of vaginal bleeding ,intra- uterine adhesions and menstruation were observed. Results Compared with control group, the volume of vaginal bleeding was less ,the time of vaginal bleeding and the recovery were shorter after treatment in observation group( P all 〈 0. 01 ). There was no intrauterine adhesion in observation group. Conclusion Drospirenone-ethinylestradiol tablets are safe and effective in women when taken immediately after artificial abortion as an option of contraception. This promotes the menstruation recovery and offers a good prevention in intrauterine adhesions.
作者 徐珉
出处 《中国临床新医学》 2012年第11期1045-1046,共2页 CHINESE JOURNAL OF NEW CLINICAL MEDICINE
关键词 人工流产 屈螺酮炔雌醇 避孕 宫腔粘连 Artificial abortion Drospirenone-ethinylestradiol tablets Contraception Intrauterine adhesion
  • 相关文献

参考文献5

二级参考文献26

  • 1郑真真,周云,郑立新,杨元,赵东霞,楼超华,赵双玲.城市外来未婚青年女工的性行为、避孕知识和实践──来自5个城市的调查[J].中国人口科学,2001(2):67-72. 被引量:31
  • 2郑红,何平,章向红,王洵,邱琇.广州市未婚人工流产女青年性行为和避孕行为调查[J].中国妇幼保健,2005,20(3):366-367. 被引量:38
  • 3Parsey KS, Pong A. An open-label, muhicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen. Contraception, 2000, 61:105- 111.
  • 4Muhn P, Fuhrmann U, Fritzemeier KH, et al. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Ann N Y Acad Sci, 1995,761:311-335.
  • 5Runnenbaum B, Rabe T. Gynakologische Endokrinologie. Berlin: Springer, 1994:413.
  • 6Oelkers WH. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy. Climacteric, 2005,8 suppl 3 : 19-27.
  • 7Burke AE, Blumenthal PD. Successful use of oral contraceptives. Semin Repord Med, 2001,19:313-321.
  • 8Borges LE, Andrade RP, Aldrighi JM, et al. Effect of a combination of ethinylestradiol 30 μg and drospirenone 3 mg on tolerance, cycle control, general well-being and fluid-related symptoms in women with premenstrual disorders requesting contraception. Contraception, 2006,74:446-450.
  • 9Brown C, Ling F, Wan J. A new monophasic oral contraceptive containing drospirenone. Effect on premenstrual symptoms. J Reprod Med,2002,47 : 14-22.
  • 10Dell DL. Premenstrual syndrome, premenstrual dysphoric disorder, and premenstrual exacerbation of another disorder. Clin Obstet Gynecol, 2004,47:568-575.

共引文献336

同被引文献22

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部